CURRICULUM VITAE 2012, March

Size: px
Start display at page:

Download "CURRICULUM VITAE 2012, March"

Transcription

1 CURRICULUM VITAE 2012, March OVERVIEW INFORMATION Name: MARHOUM EL FILALI Kamal Date and birthplace: July 16, 1958 in Casablanca, Sex: Male Nationality: Moroccan Contact Information: Business contact Personal details Address: Faculté de Médecine Address: Résidence Mawlid 3, Appt C54 19, Rue Tarik Bnou Ziad Rue Abou Taour Casablanca, Casablanca, Tel: Tel: Fax: Areas of expertise: - Clinical experience in infectious diseases, particularly in care of HIV infected patients - Quantification of antiretroviral drugs needs for HIV infected patients in - HIV/AIDS prevention campaigns - Evaluation of projects related to HIV/AIDS - Education and training in the field of infectious diseases and HIV infection Expertise related to HIV/AIDS - In : Collaboration with the National AIDS Program Commitment in the Moroccan experience of access to care and to antiretroviral therapy Involvement in many national campaigns of prevention In charge of HIV infection course in the Faculty of Medicine and Pharmacy of Casablanca - At the international level : Collaboration as consultant with UNAIDS (Republic of Congo in 2001) Contribution to the development of an african consensus on antiretroviral therapy ( Dakar, October 2000 ) Collaboration as consultant with WHO-EMRO (Republic of Yemen in 2007) Collaboration as consultant with WHO-EMRO (Republic of Syria in 2009) Currently preparing a basic training on HIV infection in collaboration with WHO-EMRO

2 EDUCATION 1993 Certificate in Infected Patient Resuscitation Xavier Bichat University Paris, France 1993 Certificate in AIDS and retroviral diseases Xavier Bichat University, Paris, France 1993 Certificate Résident Etranger du Collège de Médecine des Hôpitaux de Paris 1989 Maghreban Certificate in Health Sciences Pedagogy Collège de Médecine des Hôpitaux de Paris, France Medical School, Casablanca, 1985 MD Medical School, Casablanca, Medical School, Casablanca, 1976 Baccalaureate University of Bordeaux, France Lycée Lyautey, Casablanca, TRAINING 2010, October Antifungal preceptorship meeting. University of South Manchester, UK 2008, February Human Participants Protection Education for Research Teams NIH, online course 2007, June Advanced Course on Security WHO, online course 2006, October GCP Training for investigators Roche, Casablanca, 2006, April Course on applied regression modelling University of Bristol and University of Bern, Cape Town, South Africa 2005, July Course : Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies World Bank Institute, Beirut, Lebanon 2002, July Training : Clinical studies monitoring Georges Pompidou European Hospital, Paris, France 2001, March Atelier de mise à niveau des consultants francophones UNAIDS / WHO, Rabat, 2000, June The 2 nd african workshop on antiretrovirals Dakar, Senegal 1999, July The first African Workshop on Antiretrovirals Dakar, Senegal

3 1997, May Symposium on HIV infection Mediterranean Society of Infectious and Parasitic Diseases, Cairo, Egypt 1996, March Course on Research Methodology Medical School, Casablanca, 1995, April Course on biostatistics Medical School, Casablanca, Training : Intensive care Bichat-Claude Bernard Hospital, Paris, France 1992, June Training : Digestive endoscopia Beaujon Hospital, Paris, France 1990, January Training : HIV infection care practice Bichat-Claude Bernard Hospital Paris, France WORKING EXPERIENCES Permanent positions Since 2011 Since 2003 Since 1997 Since 1997 Since 1988 Since 1987 Head of the Infectious Diseases Unit of Ibn Rochd University Hospital. Member of the National Committee of Management of HIV infection () Responsibility of ARVs quantification for the treatment of HIV infected patients in In charge of HIV infection course in the Medical School of Casablanca National Board member of Association de Lutte Contre le Sida Physician in charge of management of HIV infection in the Infectious Diseases Unit of Ibn Rochd University Hospital Academic positions (Medical School of Casablanca) 1993 Professor of Infectious Diseases Associate Professor Assistant Resident Medical student training

4 INVOLVEMENT IN RESEARCH GRANTS : Evaluation of Subcutaneous Proleukin in a Randomized International Trial (ESPRIT001), a randomized, open label, phase III, international study of subcutaneous recombinant interleukin-2 (Proleukin ) in patients with HIV-1 infection and CD4 + Cell Counts 300/mm 3. Site principal investigator: Hakima Himmich The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 26 participants. Role in this research: Site co- investigator. Amount of money in the research grant: GBP : Study of Aldesleukin with and without Antiretroviral Therapy (STALWART : ESPRIT002), a randomized, open-label, international study of subcutaneous recombinant interleukin-2 (Aldesleukin ) with and without concomitant antiretroviral therapy in patients with HIV-1 infection and CD4 + Cell Counts 300/mm 3. Site principal investigator: Hakima Himmich The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 1 patient. Role in this research: Site co- investigator. Amount of money in the research grant: GBP : The SMART Study, a large, simple trial comparing the long-term clinical consequences of two Strategies for Management of Anti-Retroviral Therapy (Protocol CPCRA 065), the drug conservation strategy, a strategy aimed at conserving drugs through episodic use of antiretroviral treatment for the minimum time to maintain CD4+ cell count > 250 cells/mm3 versus the viral suppression strategy, a strategy aimed at suppressing viral load as much as possible, immediately following randomization and throughout follow up, irrespective of CD4+ cell count. Site principal investigator: Hakima Himmich The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has enrolled 42 patients. Role in this research: Site investigator. Amount of money in the research grant: USD ongoing : Strategic Timing of AntiRetroviral Treatment (START), a randomized study to determine whether immediate initiation of antiretroviral treatment (ART) is superior to deferral of ART until the CD4+ declines below 350 cells/mm 3 in terms of morbidity and mortality in HIV-1 infected persons who are antiretroviral naïve with a CD4+ count above 500 cells/mm 3. The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has included 21 patients and the enrolment is ongoing. Role in this research: site principal investigator. Amount of money in the research grant: USD (if the goal of 50 patients is reached) : The Antiretroviral Treatment in Lower Income Countries (ART-LINC) Collaboration to define prognosis of HIV-infected patients treated with HAART in resourcepoor settings, to compare experiences between different settings, delivery modes, and types of monitoring and to compare prognosis in resource-limited settings with that observed in industrialized nations. Principal investigators: François Dabis, Mathias Egger, Mauro Schechter The site of the Infectious Diseases Unit of Ibn Rochd University Hospital has participated with its cohort data. Role in this research: clinic representative. Research conducted by the University of Bern and the University of Bordeaux. Financial support of ANRS (France), CIHR (Canada) and NIH. Amount of money in the research grant: USD

5 CONSULTATIONS AND PROGRAMMATIC EXPERIENCE 2011 Consultation on provider initiated HIV testing in health care settings 2010 Consultation on HIV prophylaxis in case of sexual violence 2006 Consultation on sharp waste management in hospital (2 nd phase) 2004 Consultation on sharp waste management in hospital 2003 Assessment and strengthening of referral centers for HIV infection management 2001 Consultation on implementation of Access Initiative Republic of Congo UNAIDS Since 2000 Coordinator of the education program for patients under ART 2000 Contribution to the development of an African consensus on ART Casablanca Dakar, Senegal Infectious diseases unit/gsk foundation Since 1997 Consultation on ARVs procurement and supplying Since 1993 Collaboration with the National AIDS Program REGIONAL EXPERIENCE March 2009 July 2007 Syria : Consultation for the development of the GFATM proposal (WHO). Yemen : Consultation on ART for the NAP at ART sites of Sanaa and Aden (WHO) Member of the steering group of Antiretroviral Therapy in Low Income Countries (ART- LINC) collaboration Since 1994 July 2001 (Casablanca) : HIV Infection management Republic of Congo : Program Access of UNAIDS France (Paris) : HIV infection management (Casablanca) : Infectious diseases management (Casablanca) : Internal medicine diseases management.

6 PUBLICATIONS 1. Sodqi M, Marih L, Oulad Lahsen A, Bensghir R, Chakib A, Himmich H, Marhoum El Filali K. Causes de décès de 91 patients ayant une infection à VIH traités par des antirétroviraux. La Presse Médicale 2012, in press 2. Fane M, Oulad Lahsen A, Bakhatar A, Sodqi M, Marhoum El Filali K, Bahlaoui A, Chakib A. Aspergilose pulmonaire et infection à VIH (à propos de deux cas). Rev Pneumol Clin 2012, 68, 1 : Oulad Lahsen A, Rachidi T, Sodqi M, Abada R, Marhoum El Filali K. Paralysie faciale associée à la leptospirose. Médecine et Maladies Infectieuses 2010; 40, 12 : Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Marhoum El Filali K, Ezzikouri S, Abidi O, Hassar M, Wakrim L. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve HIV1-infected individuals in Casablanca,. J Infect Dev Ctries 2009; 3(5): Kamal Marhoum El Filali, Hakima Himmich, Bloodstream infections. In : a guide to infection control in hospital (fourth edition), R. Wenzel, G. Bearman, T. Brewer, J.P. Butzler (Eds). Brookline, 2008 ; Sandrine Loubière, Kamal Marhoum El Filali, Mustapha Sodqi, Anderson Loundou, Stéphane Luchini, Susan Cleary, Jean-Paul Moatti, Hakima Himmich. When to initiate highly active antiretroviral therapy in low resource settings : the Moroccan experience. Antiviral Therapy 2008 ; 13 : Gaëlle Krikorian, Kamal Marhoum El Filali, Hakima Himmich. L accès aux médicaments sous le nouveau régime de protection des brevets : cas du sida au Maroc. Knowledge Ecology Studies 2008 ; Vol.2 (Journal on-line : 8. ART-LINC Collaboration. Antiretroviral Therapy in Lower Income Countries (ART-LINC): International collaboration of treatment cohorts. Int J Epidemiol Oct;34(5): Marih L, Sodqi M, Chakib A, Malmoussi M, Ouagari Z, Marhoum El Filali K, Himmich H. Kaposi cutané de forme tumorale: difficultés diagnostiques à propos d un cas. Rev Maroc Med Santé 2005, 22, 1 : Guide de la prise en charge de l infection à VIH. Edité par le Ministère de la Santé, avec le soutien de l OMS, sous la coordination du Pr Hakima Himmich, Rabat, Malmoussi M, Zerouali K, Aajly L, Marhoum El Filali K, El Mdaghri N, Benbachir M, Himmich H. Méningite à méningocoque de l adulte à propos de 117 cas. J Magh A Réa 2003, 43 : Marih l, Sodqi M, Bensghir R, Marhoum El Filali K, Himmich H. Monitoring for efficacy of HAART in limited resource countries. Proceeding of International AIDS Conference, July Sodqi M, Marih L, Marhoum El Filali K, Himmich H. Infection with Mycobacterium tuberculosis among HIV infected patients in. Proceedings of the XIV International AIDS Conference. July Barcelone. 14. Soussi-Abdallaoui M, El Kadioui-El Idrissi F, Chakib A, Marhoum El Filali K, Himmich H, Guessous-Idrissi N. Isospora belli au Maroc à propos de 4 nouveaux cas. Les Cahiers du Medecin 2002, 48 : Marhoum El Filali K, A Chakib, Himmich H. Accès aux antirétroviraux au Maroc. Bulletin S.M.S.M 1999, 1 : Marhoum El Filali K. Prise en charge d un malade infecté par le VIH. Les cahiers du Médecin 1998 ; 11 : Marhoum El Filali K. Prophylaxie de l infection à VIH après une exposition accidentelle au sang. Les cahiers du Médecin 1998 ; 11 : Zahraoui M, Arssi M, Marhoum El Filali K, Chakib A, Himmich H. Tuberculose et infection par le VIH. Rev Maroc Med Santé 1992, 14,1 : 7-12

Noam Danenberg CEO N. Danenberg Holding Ltd noam@danenberg.co.il

Noam Danenberg CEO N. Danenberg Holding Ltd noam@danenberg.co.il Noam Danenberg CEO N. Danenberg Holding Ltd noam@danenberg.co.il Experience CEO at N. Danenberg Holding (2000) Ltd) 2000 - Present (13 years) Investment Consulting Firm Consultant at Bonzai Holding Ltd.

More information

in HIV/HCV-Coinfected Patients: role of the HCV sustained viral suppression

in HIV/HCV-Coinfected Patients: role of the HCV sustained viral suppression M42-Determinants M19 of HIV Sustained Viral Suppression in HIV/HCV-Coinfected Patients: role of the HCV sustained viral suppression F. Bani-Sadr 1-2, M-A Loko 2, E. Pambrun 2, M. Winnock 2, P. Carrieri

More information

Virologic suppression outcomes of second-line antiretroviral therapy in a Nigerian cohort.

Virologic suppression outcomes of second-line antiretroviral therapy in a Nigerian cohort. TUPE089 Virologic suppression outcomes of second-line antiretroviral therapy in a Nigerian cohort. Authors: Adedotun A. Adetunji 1, MBChB, MSc; Chad Achenbach 2, MD, MPH; Joseph Feinglass 3, PhD; Kristin

More information

National Institute of Health Administration of Morocco

National Institute of Health Administration of Morocco National Institute of Health Administration of Morocco Mission Initial training in Public Health and Health administration (Master degree) Continuous training in Public Health and Health administration

More information

CURRICULUM VITAE PERSONAL INFORMATION. Lindell A. Busciglio, M.D. 4729 North Habana Avenue Tampa, Florida 33614 (813) 251-8444

CURRICULUM VITAE PERSONAL INFORMATION. Lindell A. Busciglio, M.D. 4729 North Habana Avenue Tampa, Florida 33614 (813) 251-8444 CURRICULUM VITAE PERSONAL INFORMATION Name: Address: Lindell A. Busciglio, M.D. 4729 North Habana Avenue 33614 (813) 251-8444 4 Columbia Drive, Suite 820 33606 Research Address: 4200 North Armenia Avenue

More information

Governing Health Systems in Africa

Governing Health Systems in Africa Governing Health Systems in Africa Contents.PMD 1 Contents.PMD 2 Governing Health Systems in Africa Edited by Martyn Sama and Vinh-Kim Nguyen Council for the Development of Social Science Research in Africa

More information

Rapid Assessment of Sexual and Reproductive Health

Rapid Assessment of Sexual and Reproductive Health MOROCCO Rapid Assessment of Sexual and Reproductive Health and HIV Linkages This summary highlights the experiences, results and actions from the implementation of the Rapid Assessment Tool for Sexual

More information

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data). HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and

More information

Professor Matthew Weait Birkbeck, University of London

Professor Matthew Weait Birkbeck, University of London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Professor Matthew Weait Birkbeck, University of London 1-4 April 2014, Arena and Convention Centre Liverpool THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

More information

The Basics of Drug Resistance:

The Basics of Drug Resistance: CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu The Basics of Drug Resistance: QUESTIONS AND ANSWERS HIV Drug Resistance and ARV-Based Prevention 1. What is drug resistance?

More information

Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH

Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH TREATMENT FAILURE AND PATTERNS OF GENOTYPIC DRUG RESISTANCE MUTATIONS AMONG HAART EXPERIENCED HIV-1 PATIENTS AT KCMC Theonest Ndyetabura KILIMANJARO CHRISTIAN MEDICAL CENTRE / KILIMANJARO CLINICAL RESERCH

More information

Le métier d'infectiologue en Europe. Bruno Hoen Université de Franche Comté CHU de Besançon EGI 14 janvier 2011

Le métier d'infectiologue en Europe. Bruno Hoen Université de Franche Comté CHU de Besançon EGI 14 janvier 2011 Le métier d'infectiologue en Europe Bruno Hoen Université de Franche Comté CHU de Besançon EGI 14 janvier 2011 Une définition européenne de l'infectiologie? Les infectiologues en Europe? Pas dans tous

More information

Chairperson of the NEPAD Heads of State and Government Orientation Committee, President Macky Sall of the Republic of Senegal

Chairperson of the NEPAD Heads of State and Government Orientation Committee, President Macky Sall of the Republic of Senegal Results-based Performance Report of the NEPAD Agency Presented to 32 th NEPAD HSGOC by Dr. Ibrahim Assane Mayaki, Chief Executive Officer, NEPAD Agency 29 January 2015 Excellences, Chairperson of the NEPAD

More information

Hepatitis C Treatment of Active IV Drug Users Tania Dunn, RN Isabelle Gendron, RN B.Sc.

Hepatitis C Treatment of Active IV Drug Users Tania Dunn, RN Isabelle Gendron, RN B.Sc. Hepatitis C Treatment of Active IV Drug Users Tania Dunn, RN Isabelle Gendron, RN B.Sc. CRD Le Virage Équipe TDO GMF de l UMF Charles LeMoyne St-Lambert, Quebec February 2012 Potential Conflicts of Interest

More information

Population Pharmacokinetics of Atazanavir in Naïve HIV Infected Patients using Medication Events Monitoring System (MEMS) for drug intake timing

Population Pharmacokinetics of Atazanavir in Naïve HIV Infected Patients using Medication Events Monitoring System (MEMS) for drug intake timing Population Pharmacokinetics of Atazanavir in Naïve HIV Infected Patients using Medication Events Monitoring System (MEMS) for drug intake timing ANRS -COPHAR clinical trial Céline Verstuyft Pharmacologie,

More information

Curriculum vitae. Safy Zahid Kaddah. Assistant professor of chest diseases department, Cairo University.

Curriculum vitae. Safy Zahid Kaddah. Assistant professor of chest diseases department, Cairo University. Curriculum vitae Safy Zahid Kaddah Assistant professor of chest diseases department, Cairo University. The chest diseases department coordinate of the technical support office for projects and grants Kasr

More information

Viral load testing. medical monitoring: viral load testing: 1

Viral load testing. medical monitoring: viral load testing: 1 medical monitoring: viral load testing: 1 medical monitoring: viral load testing Viral load testing medical monitoring: viral load testing: 2 Slide 1 Viral load The viral load test measures HIV in the

More information

Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* Overview. To change category names: Instructions. 2. Introduce session.

Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* Overview. To change category names: Instructions. 2. Introduce session. Core Competencies: HIV/AIDS: HIV Basics HIV/AIDS JEOPARDY* ABOUT THIS ACTIVITY Time: 60 minutes Objectives: By the end of this session, participants will be able to: Reviewed their knowledge of HIV/AIDS

More information

HIV Guidelines. New Strategies.

HIV Guidelines. New Strategies. HIV Guidelines. New Strategies. Santiago Moreno Hospital Universitario Ramón y Cajal Madrid HIV Guidelines. New Strategies. Outline HIV Guidelines What is new? New strategies Treatment as Prevention HIV

More information

ACCESS TO AFFORDABLE TREATMENT FOR HIV/AIDS: THE ISSUES

ACCESS TO AFFORDABLE TREATMENT FOR HIV/AIDS: THE ISSUES ACCESS TO AFFORDABLE TREATMENT FOR HIV/AIDS: THE ISSUES AIDS Law Unit Legal Assistance Centre July, 2002 INTRODUCTION Although there is currently no cure for HIV/Aids, treatment has, however, been developed

More information

Réservoirs VIH : du contrôle à l'éradication. Asier Sáez-Cirión, PhD Unité de Régulation des Infections Rétrovirales

Réservoirs VIH : du contrôle à l'éradication. Asier Sáez-Cirión, PhD Unité de Régulation des Infections Rétrovirales Réservoirs VIH : du contrôle à l'éradication Asier Sáez-Cirión, PhD Unité de Régulation des Infections Rétrovirales M. Coiras et al Nat Rev Micro 2009 HIV-1 life cycle and latency HIV-1 life cycle and

More information

Guideline. Treatment of tuberculosis in patients with HIV co-infection. Version 3.0

Guideline. Treatment of tuberculosis in patients with HIV co-infection. Version 3.0 Guideline Treatment of tuberculosis in patients with HIV co-infection Version 3.0 Key critical points Co-infection with Tuberculosis (TB) and HIV is common in many parts of the world, especially sub-saharan

More information

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants hiv/aids Programme Programmatic update Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants EXECUTIVE SUMMARY April 2012 EXECUTIVE SUMMARY Recent developments

More information

Global Update on HIV Treatment 2013: Results, Impact and Opportunities

Global Update on HIV Treatment 2013: Results, Impact and Opportunities June 2013 Global Update on HIV Treatment 2013: Results, Impact and Opportunities WHO/UNAIDS/UNICEF v2 Outline Results: Progress towards Global Targets - Antiretroviral treatment - Prevention of mother-to-child

More information

Without AIDS Scenario Population (1,000s) 10,186 10,978 Growth rate 2.8 2.9 Crude birth rate 40 39 Crude death rate 14 12

Without AIDS Scenario Population (1,000s) 10,186 10,978 Growth rate 2.8 2.9 Crude birth rate 40 39 Crude death rate 14 12 Demographic Indicators With AIDS Series Without AIDS Scenario With AIDS Series Without AIDS Scenario Population (1,s),186,978 Growth rate 2.8 2.9 Crude birth rate 4 39 Crude death rate 14 12 Infant mortality

More information

Synthesis of ECT evidence

Synthesis of ECT evidence Efficacy Synthesis of ECT evidence Risk Reference : Agence d évaluation des technologies et des modes d intervention en santé (AETMIS). The use of electroconvulsive therapy in Québec. Report prepared by

More information

Frequently Asked Questions (FAQs)

Frequently Asked Questions (FAQs) Frequently Asked Questions (FAQs) Research Rationale 1. What does PrEP stand for? There is scientific evidence that antiretroviral (anti-hiv) medications may be able to play an important role in reducing

More information

HIV New Diagnoses, Treatment and Care in the UK 2015 report

HIV New Diagnoses, Treatment and Care in the UK 2015 report HIV New Diagnoses, Treatment and Care in the UK 2015 report About Public Health England Public Health England exists to protect and improve the nation's health and wellbeing, and reduce health inequalities.

More information

FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT

FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT FEDERAL BUREAU OF PRISONS REPORT ON INFECTIOUS DISEASE MANAGEMENT What is the purpose of this report? The purpose of this report is to present the administrative policies and clinical guidelines for the

More information

HIV/AIDS Prevention and Care

HIV/AIDS Prevention and Care HIV/AIDS Prevention and Care Nancy S. Padian, PhD, MPH Professor, Obstetrics, Gynecology & Reproductive Sciences Associate Director for Research, Global Health Sciences and AIDS Research Institute: University

More information

APPENDIX C: Viral Load Suppression Measures

APPENDIX C: Viral Load Suppression Measures Newark EMA HIV Health Services Planning Council Needs Assessment 2012 Update APPENDIX C: Viral Load Suppression Measures Page C-1 APPENDIX C: Viral Load Suppression Measures in+care Campaign Measures November

More information

Aids Fonds funding for programmes to prevent HIV drug resistance

Aids Fonds funding for programmes to prevent HIV drug resistance funding for programmes to prevent HIV drug resistance Call for proposals July 2012 Page 1 van 10 grants@aidsfonds.nl Documentnumber 20120719/JKA/RAP Universal Access Lifting barriers to universal access

More information

EYE DISEASES IN HIV-INFECTED INDIVIDUALS IN RURAL SOUTH AFRICA

EYE DISEASES IN HIV-INFECTED INDIVIDUALS IN RURAL SOUTH AFRICA EYE DISEASES IN HIV-INFECTED INDIVIDUALS IN RURAL SOUTH AFRICA In our Western world where treatment is available, HIV/AIDS has become a chronic disease. In all other parts of the globe, HIV/AIDS is still

More information

Session 4: The Drug Management Cycle: Selection. David Peters

Session 4: The Drug Management Cycle: Selection. David Peters This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Curriculum Vitae Nadia NAAMI

Curriculum Vitae Nadia NAAMI Nadia Naami Ph.D. Candidate in Romance Studies Department of Modern Languages and Literatures University of Miami 5202 University Drive Coral Gables, FL 33124-2074 Tel: 786-603-8795 email :n.naami@umiami.edu

More information

HIV/AIDS Care: The Diagnosis Code Series 2. Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer

HIV/AIDS Care: The Diagnosis Code Series 2. Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer HIV/AIDS Care: The Diagnosis Code Series 2 Prepared By: Stacey L. Murphy, MPA, RHIA, CPC AHIMA Approved ICD-10-CM/ICD-10-CM Trainer Learning Outcomes Identify and explain the difference between ICD-9-CM

More information

Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB

Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB Incidencia y Características Clínicas del Síndrome Inflamatorio de Reconstitución Inmune (IRIS) en el Contexto de la Coinfección VIH-TB Dr. Christian Manzardo Hospital Clínic/IDIBAPS- Universidad de Barcelona

More information

In Tanzania, ARVs were introduced free-of-charge by the government in 2004 and, by July 2008, almost 170,000 people were receiving the drugs.

In Tanzania, ARVs were introduced free-of-charge by the government in 2004 and, by July 2008, almost 170,000 people were receiving the drugs. ANTIRETROVIRAL TREATMENT What is ART and ARV? ART is a short form for Antiretroviral Therapy (or Treatment). Antiretroviral therapy is a treatment consisting of a combination of drugs which work against

More information

Paediatric HIV Drug Resistance in African Settings

Paediatric HIV Drug Resistance in African Settings Paediatric HIV Drug Resistance in African Settings Dr Cissy Kityo Mutuluuza INTEREST Meeting May 5-9, 2014 Lusaka, Zambia Background: ART for children in sub- Saharan Africa 2.3 million children with HIV

More information

Expérience appui ANR Zimbabwe (Medicines Control Authority of Zimbabwe -MCAZ) Corinne Pouget -AEDES

Expérience appui ANR Zimbabwe (Medicines Control Authority of Zimbabwe -MCAZ) Corinne Pouget -AEDES Expérience appui ANR Zimbabwe (Medicines Control Authority of Zimbabwe -MCAZ) Corinne Pouget -AEDES 1 Zimbabwe Pharmaceutical Industry The Market Small Country of ca.13 million people Human Pharmaceutical

More information

INTERVENTION PROVIDING FEEDBACK TO PHYSICIANS AND PHARMACISTS TO IMPROVE DRUG USE

INTERVENTION PROVIDING FEEDBACK TO PHYSICIANS AND PHARMACISTS TO IMPROVE DRUG USE INTERVENTION PROVIDING FEEDBACK TO PHYSICIANS AND PHARMACISTS TO IMPROVE DRUG USE Final Report Submitted to the Canadian Health Services Research Foundation October 2004 Régis Blais, Ph.D. Claudine Laurier,

More information

The Value of Innovation in HIV/AIDS Therapy

The Value of Innovation in HIV/AIDS Therapy White Paper September 2014 The Value of Innovation in HIV/AIDS Therapy Erin Ellwanger, Harrison Kim, and Thomas Goss, PharmD Boston Healthcare Associates, Inc. Boston; Washington, D.C.; Berlin; Shangai;

More information

HIV DRUG RESISTANCE EARLY WARNING INDICATORS

HIV DRUG RESISTANCE EARLY WARNING INDICATORS HIV DRUG RESISTANCE EARLY WARNING INDICATORS World Health Organization indicators to monitor HIV drug resistance prevention at antiretroviral treatment sites June 2010 Update ACKNOWLEDGEMENTS The preparation

More information

Stigma and Discrimination

Stigma and Discrimination Stigma and Discrimination T he Network of Associations for Harm Reduction (NAHR) aims to reduce HIV/AIDS Stigma and Discrimination towards Most at Risk Populations (MARPs) and People Living with HIV/AIDS

More information

NATIONAL UNIVERSITY OF RWANDA HIV/AIDS CONTROL POLICY

NATIONAL UNIVERSITY OF RWANDA HIV/AIDS CONTROL POLICY NATIONAL UNIVERSITY OF RWANDA HIV/AIDS CONTROL POLICY 1 I. BACKGROUND Since the beginning of the HIV/AIDS pandemic, sub-saharan Africa is one of the most severely affected regions. According to the 2006

More information

Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries

Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries Protocol for the systematic review of virological outcomes after 12 Months of antiretroviral therapy in low and middle income countries 1. Authors James H. McMahon Alfred Hospital, Melbourne, Australia

More information

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents Visit the AIDSinfo website to access the most up-to-date guideline. Register for e-mail notification of guideline

More information

EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO

EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO EXPANDED HIV TESTING AND LINKAGE TO CARE (X-TLC) IN HEALTHCARE SETTINGS ON THE SOUTH SIDE OF CHICAGO R Eavou, M Taylor, C Bertozzi-Villa, D Amarathithada, R Buffington, D Pitrak and N Benbow HIV Prevention

More information

VICTOR NABHAN. Short CV. Victor Nabhan holds LLM law degrees from the University of Lyon, University of Paris, and New York University Law Schools.

VICTOR NABHAN. Short CV. Victor Nabhan holds LLM law degrees from the University of Lyon, University of Paris, and New York University Law Schools. VICTOR NABHAN Short CV Victor Nabhan holds LLM law degrees from the University of Lyon, University of Paris, and New York University Law Schools. From 1971 until 1999 a) He was a professor of law (tenured)

More information

Routine HIV Monitoring

Routine HIV Monitoring Routine HIV Monitoring Guideline of the HIV/AIDS Division at San Francisco General Hospital Statement of Guideline: Patients will be routinely evaluated and monitored for HIV parameters, antiretroviral

More information

Case Finding for Hepatitis B and Hepatitis C

Case Finding for Hepatitis B and Hepatitis C Case Finding for Hepatitis B and Hepatitis C John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention Atlanta, Georgia, USA Division of Viral Hepatitis National Center

More information

5èmes journées du Site ANRS-Cameroun Yaoundé, 3-4 juin 2013 ANRS-12235

5èmes journées du Site ANRS-Cameroun Yaoundé, 3-4 juin 2013 ANRS-12235 èmes journées du Site ANRS-Cameroun Yaoundé, -4 juin 201 ANRS-122 Le sang total séché sur papier filtre, DBS (Dried Blood Spot), est-il utilisable pour le suivi virologique en routine des patients VIH+

More information

International Symposium "Water, Recycling and Waste Valorisation ", ERVD 3 Conference center FMP-Fez, Morocco, 28 and 29 October 2015.

International Symposium Water, Recycling and Waste Valorisation , ERVD 3 Conference center FMP-Fez, Morocco, 28 and 29 October 2015. Groupe de Réflexion sur le Développement Durable 32, Rue Michlifène Lot Al Ghorfa, Rte Aïn Smen, 30 040 Fès Tél. 0672 351 191 E-mail. zerrouq1959@gmail.com Site web: www.qualisup.com International Symposium

More information

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management

Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management Bloodborne Pathogens Exposure Policy and Procedures Employees of the State of South Dakota Department of Health Bloodborne Pathogens (HIV, HBV, and HCV) Exposure Management PEP Hotline 1-888-448-4911 DOH

More information

HIV Therapy Key Clinical Indicator (KCI)

HIV Therapy Key Clinical Indicator (KCI) Publication Report HIV Therapy Key Clinical Indicator (KCI) Year ending 31 December 2010 Publication date 27 September 2011 A National Statistics Publication for Scotland Contents Contents... 1 About ISD...

More information

Telephone: 514-878-2691 Email: parent.nicole@rcgt.com

Telephone: 514-878-2691 Email: parent.nicole@rcgt.com NICOLE PARENT, RN PHD Telephone: 514-878-2691 Email: parent.nicole@rcgt.com CAREER PROFILE Nicole Parent, RN, PhD is a Senior Consultant in s Strategy and Performance Consulting Group. She is also a nurse

More information

New Approaches to a Major Public-Health Problem Infectious Diseases. Ethan Weiner, M.D. Senior Vice President Therapeutic Area Development Head

New Approaches to a Major Public-Health Problem Infectious Diseases. Ethan Weiner, M.D. Senior Vice President Therapeutic Area Development Head New Approaches to a Major Public-Health Problem Infectious Diseases Ethan Weiner, M.D. Senior Vice President Therapeutic Area Development Head Overview The Burden Of Infectious Disease Is Large And May

More information

P Colson1,2,3, F Gouriet1,2,3, S Badiaga2,4, C Tamalet1,2, A Stein2,5, D Raoult1,2 (didier.raoult@gmail.com)

P Colson1,2,3, F Gouriet1,2,3, S Badiaga2,4, C Tamalet1,2, A Stein2,5, D Raoult1,2 (didier.raoult@gmail.com) Rapid communication Real-time laboratory surveillance of sexually-transmissible infections in Marseille University hospitals reveals rise of gonorrhoea, syphilis and human immunodeficiency virus seroconversions

More information

Presented By: Amy Medley PhD, MPH Centers for Disease Control and Prevention

Presented By: Amy Medley PhD, MPH Centers for Disease Control and Prevention Factors Associated with Non-Adherence to Antiretroviral Therapy among Patients Attending HIV Care and Treatment Clinics in Kenya, Namibia, and Tanzania Harriet Nuwagaba-Biribonwoha, Sherri Pals, Daniel

More information

Module 7: The Role of the Nurse

Module 7: The Role of the Nurse Module 7: The Role of the Nurse Module Objectives To describe the dynamic role of the nurse in the holistic care of a patient receiving ARV treatment To equip nurses with a sense of importance and belief

More information

The use of alcohol and drugs and HIV treatment compliance in Brazil

The use of alcohol and drugs and HIV treatment compliance in Brazil The use of alcohol and drugs and HIV treatment compliance in Brazil André Malbergier, MD, PhD Hospital das Clínicas Medical School University of São Paulo Brasil The Casa da AIDS offers specialized integral

More information

The use of ARVs in HIV prevention and the case for optimizing the preventive impact of ART?

The use of ARVs in HIV prevention and the case for optimizing the preventive impact of ART? World Health Organization brief on antiretroviral treatment (ART) in HIV and TB prevention. Date: January 2011 This brief is intended as an introduction for WHO staff to the HIV and TB preventive benefit

More information

CURRICULUM VITAE. Mohamed Ali BCHIR PERSONNAL INFORMATIONS

CURRICULUM VITAE. Mohamed Ali BCHIR PERSONNAL INFORMATIONS CURRICULUM VITAE Mohamed Ali BCHIR PERSONNAL INFORMATIONS Address: ENGEES Tunisian Single 1, quai Koch - BP61039 UMR GESTE Born on April, 29 th 1980 67070 Strasbourg Driving License B Office: + 33 3 88

More information

HIV 201: What I Wish I Knew as a NEW RN

HIV 201: What I Wish I Knew as a NEW RN NORTHWEST AIDS EDUCATION AND TRAINING CENTER HIV 201: What I Wish I Knew as a NEW RN Andrea Carriedo, RN The New Hope Clinic NO CONFLICTS OF INEREST OR RELATIONSHIPS TO DISCLOSE Objectives Describe the

More information

L hépatite virale C en Médecine Familiale- Rurale Montréal-Québec Mai 2015

L hépatite virale C en Médecine Familiale- Rurale Montréal-Québec Mai 2015 L hépatite virale C en Médecine Familiale- Rurale Montréal-Québec Mai 2015 Demographics Luis Rivero Pinelo MD LMCC, CCFP, FCFP, Fellow SRPC, CSPQ Shawville- Québec Aux États Unis, la prévalence est présente

More information

Linda Beer, PhD and Jacek Skarbinski, MD for the Medical Monitoring Project

Linda Beer, PhD and Jacek Skarbinski, MD for the Medical Monitoring Project Adherence to Antiretroviral Therapy and Disparities in Viral Suppression among U.S. Black and White Men Who Have Sex With Men Medical Monitoring Project, 2009 Linda Beer, PhD and Jacek Skarbinski, MD for

More information

Comparative Drug Ranking for Clinical Decision Support in HIV Treatment

Comparative Drug Ranking for Clinical Decision Support in HIV Treatment Comparative Drug Ranking for Clinical Decision Support in HIV Treatment Emiliano Mancini University of Amsterdam 1 Prevalence of HIV 2 Global Overview HIV Infection People living with HIV: 34 million (2010

More information

Improving primary care management of depression in adults with comorbid chronic illnesses

Improving primary care management of depression in adults with comorbid chronic illnesses Executive summary of current research Improving primary care management of depression in adults with comorbid chronic illnesses Principal Investigator Jane McCusker, MD DrPH Co-Investigators Martin Cole,

More information

GARPR Online Reporting Tool

GARPR Online Reporting Tool GARPR Online Reporting Tool 0 Narrative Report and Cover Sheet 1) Which institutions/entities were responsible for filling out the indicator forms? a) NAC or equivalent Yes b) NAP Yes c) Others Yes If

More information

Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania

Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania Antiviral Therapy 13 Suppl 2:77 82 Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania Geofrey R Somi 1, Tabitha Kibuka 2, Karidja Diallo

More information

Estelle BROSSET Senior lecturer with habilitation to supervise doctoral theses Jean Monnet Chair Section 02- Public law

Estelle BROSSET Senior lecturer with habilitation to supervise doctoral theses Jean Monnet Chair Section 02- Public law Estelle BROSSET Senior lecturer with habilitation to supervise doctoral theses Jean Monnet Chair Section 02- Public law Professional address: Centre d Etudes et de Recherches Internationales et Communautaires

More information

CURRICULUM VITAE PERSONAL INFORMATION. Scott S. Ubillos, M.D.

CURRICULUM VITAE PERSONAL INFORMATION. Scott S. Ubillos, M.D. CURRICULUM VITAE PERSONAL INFORMATION Name: Scott S. Ubillos, M.D. Office Infectious Disease Associates of Tampa Bay Address: 4 Columbia Drive, Suite 820 Tampa, FL 33606 4729 N. Habana Ave Tampa, Florida

More information

HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline

HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline Background... 2 Screening... 2 Recommendations... 2 Ordering and consent... 2 Indications for Periodic HIV Screening...

More information

Report to UNAIDS HIV/AIDS TRENDS IN JAPAN April 2016

Report to UNAIDS HIV/AIDS TRENDS IN JAPAN April 2016 Report to UNAIDS HIV/AIDS TRENDS IN JAPAN April 2016 I. Status at a glance The AIDS Surveillance Committee holds quarterly meeting to compile the annual report on the trends of new reported cases of HIV

More information

Under the title: Quality in Higher Education, for meet the needs of Enterprise and the Moroccan Society: Approaches, Practices and Evaluation Systems

Under the title: Quality in Higher Education, for meet the needs of Enterprise and the Moroccan Society: Approaches, Practices and Evaluation Systems Under the title: Quality in Higher Education, for meet the needs of Enterprise and the Moroccan Society: Approaches, Practices and Evaluation Systems The Research Group on QHSE Sidi Mohamed Ben Abdellah

More information

Chris Beyrer, MD, MPH President-Elect, International AIDS Society

Chris Beyrer, MD, MPH President-Elect, International AIDS Society Chris Beyrer, MD, MPH President-Elect, International AIDS Society Chris Beyrer MD, MPH, is Professor of epidemiology, International Health and Health, Behavior and Society at the Johns Hopkins Bloomberg

More information

SOCIAL COST OF HIV INFECTION IN SWITZERLAND

SOCIAL COST OF HIV INFECTION IN SWITZERLAND SOCIAL COST OF HIV INFECTION IN SWITZERLAND FINAL REPORT Pascal Zurn (1), Patrick Taffé (2), Martin Rickenbach (2), Jean-Pierre Danthine (3) (1) Institut d Economie et de Management de la Santé, Lausanne

More information

Table 5: HIV/AIDS statistics for Africa (excluding North Africa), 2001 and 2009

Table 5: HIV/AIDS statistics for Africa (excluding North Africa), 2001 and 2009 Table 5: HIV/AIDS statistics for Africa (excluding North Africa), 2001 and 2009 Year People living with HIV (million) People newly infected with HIV (million) Children living with HIV (million) AIDS-related

More information

João Silva de Mendonça, MD, PhD Infectious Diseases Service Hospital do Servidor Público Estadual São Paulo - Brazil

João Silva de Mendonça, MD, PhD Infectious Diseases Service Hospital do Servidor Público Estadual São Paulo - Brazil Brazilian Ministry of Health, Brazilian Society of Hepatology PAHO, Viral Hepatitis Prevention Board PART III SESSION 9 Prevention and control of Viral Hepatitis in Brazil HEPATITIS IN SPECIAL RISK GROUPS/

More information

UNAIDS 2014 LESOTHO HIV EPIDEMIC PROFILE

UNAIDS 2014 LESOTHO HIV EPIDEMIC PROFILE UNAIDS 214 LESOTHO HIV EPIDEMIC PROFILE 214 LESOTHO Overview The Kingdom of Lesotho is landlocked and surrounded by South Africa. It has a surface area of 3 355 square kilometres and its population is

More information

Co-infected health-care workers

Co-infected health-care workers Co-infected health-care workers Y.Yazdanpanah Service Universitaire des Maladies Infectieuses et du Voyageur C.H. Tourcoing, Faculté de Médecine de Lille CNRS U362, Lille, France Co-infected health-care

More information

State of Alabama HIV Surveillance 2012 Annual Report Finalized

State of Alabama HIV Surveillance 2012 Annual Report Finalized State of Alabama HIV Surveillance 212 Annual Report Finalized Prepared by: Division of HIV/AIDS Prevention and Control HIV Surveillance Branch Contact Person: Allison R. Smith, MPH Allison.Smith@adph.state.al.us

More information

HIV Drug resistanceimplications

HIV Drug resistanceimplications HIV Drug resistanceimplications for therapy Deenan Pillay Africa Centre for Health and Population Studies, UKZN University College London Potential implications of HAART without virological monitoring:

More information

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges John B. Kaneene, DVM, MPH, PhD University Distinguished Professor of Epidemiology Director, Center for Comparative Epidemiology

More information

Routine testing to reduce late HIV diagnosis in France.

Routine testing to reduce late HIV diagnosis in France. Routine testing to reduce late HIV diagnosis in France. Cyrille Delpierre, Lise Cuzin, France Lert To cite this version: Cyrille Delpierre, Lise Cuzin, France Lert. Routine testing to reduce late HIV diagnosis

More information

2 RENSEIGNEMENTS CONCERNANT L ASSURÉ SI CELUI-CI N EST PAS LE REQUÉRANT INFORMATION CONCERNING THE INSURED PERSON IF OTHER THAN THE APPLICANT

2 RENSEIGNEMENTS CONCERNANT L ASSURÉ SI CELUI-CI N EST PAS LE REQUÉRANT INFORMATION CONCERNING THE INSURED PERSON IF OTHER THAN THE APPLICANT SÉCURITÉ SOCIALE SOCIAL SECURITY ACCORD DU 9 FÉVRIER 1979 ENTRE LA FRANCE ET LE CANADA AGREEMENT OF FEBRUARY 9, 1979 BETWEEN FRANCE AND CANADA Formulaire FORM SE 401-06 INSTRUCTION D UNE DEMANDE DE PENSION

More information

Ministère des Affaires Sociales et de la Santé, France

Ministère des Affaires Sociales et de la Santé, France Ministère des Affaires Sociales et de la Santé, France 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: 1. Respondent Profile Public authorities

More information

Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections

Chapter 36. Media Directory. Characteristics of Viruses. Primitive Structure of Viruses. Therapy for Viral Infections. Drugs for Viral Infections Chapter 36 Media Directory Drugs for Viral Infections Slide 23 Slide 27 Slide 29 Zidovudine Animation Saquinavir Mesylate Animation Acyclovir Animation Upper Saddle River, New Jersey 07458 All rights reserved.

More information

Please describe the laboratory facilities available in your research institute, including the items listed below (if applicable):

Please describe the laboratory facilities available in your research institute, including the items listed below (if applicable): Institution: Makerere University College of Health Sciences [MakCHS] and Makerere School of Public Health [MakSPH] Kampala, Uganda http://chs.mak.ac.ug/ Contact: Jacinta Oyella [MakCHS] Physician oyella1@yahoo.com

More information

Journal of Infectious Diseases Advance Access published January 26, 2015

Journal of Infectious Diseases Advance Access published January 26, 2015 Journal of Infectious Diseases Advance Access published January 26, 2015 1 Effect of immune status on serial QuantiFERON-TB Gold In-Tube LTBI screening in persons with HIV in a low TB incidence country

More information

The Prize Fund for HIV/AIDS

The Prize Fund for HIV/AIDS The Prize Fund for HIV/AIDS A New Paradigm for Supporting Sustainable Innovation and Access to New Drugs for AIDS: De-Linking Markets for Products from Markets for Innovation May 26, 2011 Introduction

More information

Georges Corm Economic & Financial Consultancy Office

Georges Corm Economic & Financial Consultancy Office Georges Corm Economic & Financial Consultancy Office Since 1985 Office n 906, Starco centre (Block A), Georges Picot street, Mina El Hosn, Beirut, Lebanon Tel & Fax: 961 1 370130 365697 E-mail: gecorm@inco.com.lb

More information

ACCESS TO ANTIRETROVIRAL THERAPY IN AFRICA STATUS REPORT ON PROGRESS TOWARDS THE 2015 TARGETS

ACCESS TO ANTIRETROVIRAL THERAPY IN AFRICA STATUS REPORT ON PROGRESS TOWARDS THE 2015 TARGETS ACCESS TO ANTIRETROVIRAL THERAPY IN AFRICA STATUS REPORT ON PROGRESS TOWARDS THE 2015 TARGETS EARLY INITIATION OF ANTIRETROVIRAL THERAPY IS CRUCIAL TO THE AIDS RESPONSE Achieving the vision of zero new

More information

1 Announcement Call for papers

1 Announcement Call for papers International Congress Mycotoxins and Cancer Mycotoxins and Cancer Marrakesh from 02 till 04 december 2015 nd th Hôtel Ryad Mogador Agdal st 1 Announcement Call for papers contact@mycotoxine-marrakech2015.ma

More information

WHO-EM/STD/144/E. Towards the elimination of mother-to-child transmission of HIV. Conceptual framework for the Middle East and North Africa Region

WHO-EM/STD/144/E. Towards the elimination of mother-to-child transmission of HIV. Conceptual framework for the Middle East and North Africa Region WHO-EM/STD/144/E Towards the elimination of mother-to-child transmission of HIV Conceptual framework for the Middle East and North Africa Region WHO-EM/STD/144/E Towards the elimination of mother-to-child

More information

Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health

Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health Introduction Reader (Statistics and Epidemiology) Research team epidemiologists/statisticians/phd students Primary care

More information

Borderless Diseases By Sunny Thai

Borderless Diseases By Sunny Thai Borderless Diseases By Sunny Thai Millennium Development Goal #6 6. Combat HIV/AIDS, malaria and other borderless diseases. A. Halt and begin reversing spread of HIV by 2015. B. Achieve universal access

More information

Immunology Platform 2012

Immunology Platform 2012 Immunology Platform 2012 The scientific activity report of Immunology Platform of the Institut Pasteur du Cambodge for the period January 1st to December 31st, 2012. Scientific activity report Prepared

More information

UNAIDS 2013 AIDS by the numbers

UNAIDS 2013 AIDS by the numbers UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since

More information